Pharmacodynamics of the orexin type 1 (OX 1 ) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17422 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Valérie Gratio und 7 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR1149/Inflammation Research Center (CRI), Team "From Inflammation to Cancer in Digestive diseases (INDiD)", DHU UNITY, Université Paris Cité…. Hauptthemen laut MEDLINE: Orexin Receptors, Colonic Neoplasms, Orexins, GTP-Binding Protein alpha Subunits, Gq-G11. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ligue Contre le Cancer, Institut National du Cancer (INCA), PLGrid (HPC Center: ACC Cyfronet AGH).
Abstract (Originalsprache)
Background and Purpose Orexins have important biological effects on the central and peripheral nervous systems. Their primary ability is to regulate the sleep–wake cycle. Orexins and their antagonists, via OX 1 receptor have been shown to have proapoptotic and antitumor effects on various digestive cancers cell models. We investigated, (1) the ability of orexin‐A and its antagonists to regulate OX 1 receptor expression at the cell surface and (2), how OX 1 antagonists induced proapoptotic effect in cancer cell s models. Experimental Approach The OX 1 receptor internalisation is determined by imaging flow cytometry in colon cancer cell models and the OX 1 receptor coupling to G proteins via bioluminescence resonance energy transfer and molecular dynamic simulation. Key Results Orexin‐A induced rapid receptor internalisation within 15 min via β‐arrestin 2 recruitment, whereas antagonists had no effect. Furthermore, Gq is critical for receptor internalisation and signalling pathways, and no other G proteins appear to be recruited. Surprisingly, antagonists induced recruitment and conformational changes in Gq protein. Simulated molecular dynamics of agonists/orexin receptor/Gq complexes show that antagonists exhibits a similar binding mode, stable at the binding site and show conformational changes of ECL2, similar to that of the agonists. Conclusion and Implications OX 1 receptor activation induced orexin/β‐arrestin‐dependent internalisation, which was independent of the apoptotic pathway induced by orexins and antagonists. In addition, antagonists activate the Gq protein, suggesting its putative partial dissociation. These results suggest that the development of OX 1 receptor targeting molecules, including orexin antagonists with antitumor properties, may pave the way for innovative cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM UMR1149/Inflammation Research Center (CRI), Team "From Inflammation to Cancer in Digestive diseases (INDiD)", DHU UNITY, Université Paris Cité, Paris, France.
- INSERM UMR1149/Inflammation Research Center (CRI), Flow Cytometry Platform (CytoCRI), DHU UNITY, Université Paris Cité, Paris, France.
- Faculty of Chemistry, University of Warsaw, Warsaw, Poland.
- INSERM UMR1149/Inflammation Research Center (CRI), Team "Antigen Presentation by Dendritic Cells to T cells (APreT)", DHU UNITY, Université Paris Cité, Paris, France.
ORCID-Profile: Valérie Gratio, Paulina Dragan, Loredana Saveanu, Pascal Nicole, Thierry Voisin, Dorota Latek, Alain Couvineau
Förderung
- Ligue Contre le Cancer
- Institut National du Cancer (INCA)
- PLGrid (HPC Center: ACC Cyfronet AGH)
- Institut National de la Santé et de la Recherche Medicale
- Université Paris Cité
- Ligue Nationale Contre le Cancer
- ERNEST COST Action
- National Science Centre in Poland
Zitieren
APA
Gratio, V., Dragan, P., Garcia, L., Saveanu, L., Nicole, P., Voisin, T., Latek, D., & Couvineau, A. (2025). Pharmacodynamics of the orexin type 1 (OX 1 ) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq. British Journal of Pharmacology. https://doi.org/10.1111/bph.17422
Vancouver
Gratio V, Dragan P, Garcia L, Saveanu L, Nicole P, Voisin T, et al. Pharmacodynamics of the orexin type 1 (OX 1 ) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq. British Journal of Pharmacology. 2025. doi:10.1111/bph.17422
BibTeX
@article{Gratio2025,
author = {Gratio, Valérie and Dragan, Paulina and Garcia, Laurine and Saveanu, Loredana and Nicole, Pascal and Voisin, Thierry and Latek, Dorota and Couvineau, Alain},
title = {Pharmacodynamics of the orexin type 1 (OX 1 ) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17422}
}
EUVIMED